“●아깝지않은●WWW˛ yeotop5.com 대야동오피❤대야동풀싸롱え대야동오피Ⅰ대야동안마ぺ대야동휴게텔た대야동건마✢대야동OP”的搜索结果，显示 331-340 项，共有 16052 项

1. Tubular adenoma of the colon - 诊断与治疗- 妙佑医疗国际

   Recommended next colonoscopy. 1 to 2 small (< 10 mm) tubular adenomas, 7 ... 1 year. Our caring team of Mayo Clinic experts can help you with your tubular ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to monitor T cell responses from patients with advanced cancer who are being treated with an anti-PD (programmed death)-1 ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007). Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The primary objective of the ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, ...

8. 神经外科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6- ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 1-2 prior lines of therapy. The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); in the absence ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression ...